| Literature DB >> 19669686 |
Tiny A de Boer1, Alfredo L Milani, Kirsten B Kluivers, Mariella I J Withagen, Mark E Vierhout.
Abstract
INTRODUCTION AND HYPOTHESIS: The objective of this study is to evaluate cervical amputation with uterosacral ligament plication (modified Manchester) and compare it to vaginal hysterectomy with high uterosacral ligament plication procedure with special regard to the middle compartment.Entities:
Mesh:
Year: 2009 PMID: 19669686 PMCID: PMC2762528 DOI: 10.1007/s00192-009-0945-3
Source DB: PubMed Journal: Int Urogynecol J Pelvic Floor Dysfunct
Fig. 1a Schematic diagram to illustrate the modified Sturmdorf suture on the posterior side after the amputation of the cervix. The suture starts at the left uterosacral ligament about 1 1/2 cm from the amputated cervix (1). With a deep bite through the cervix, it comes out close to the cervical canal (2). It then takes a superficial double bite through the posterior vaginal wall (3 and 4), after which, another deep bite through the cervix starting in or close to the cervical canal (5) comes out in the right uterosacral ligament around 1 1/2 cm from the amputated cervix (6). b After tying this suture, the two uterosacral ligaments (1 and 6) are united in the midline. There now is a double layer of epithelium between the ligaments. This technique shortens the uterosacral ligaments and thus elevates the uterus. It also partially closes the pouch of Douglas and, thus, has a preventive effect on the development of an enterocele. Posteriorly, the raw amputated surface of the cervix is now covered with vaginal epithelium (3 and 4)
Baseline patient’s characteristics
| Cervical amputation ( | Vaginal hysterectomy ( |
| |
|---|---|---|---|
| Age (years)a | 58 (34, 83) | 57 (34, 87) | 0.542 |
| Paritya | 2 (0, 10) | 2 (1, 8) | 0.476 |
| Body Mass Index (kg/m2)a | 24 (19, 41) | 25(19, 31) | 0.966 |
| Postmenopausal status | 44 (55) | 38 (51) | 0.552 |
| Hormonal replacement therapyb | 5 (6) | 3 (4) | |
| Previous urogynaecological surgeryc | |||
| Anterior compartment | 5 (6) | 5 (7) | 0.882 |
| Posterior compartment | 6 (7) | 6 (8) | 0.870 |
| Middle compartment | 2 (3) | 1 (2) | 0.614 |
| Incontinence surgery | 5 (6) | 5 (7) | 0.917 |
| Comorbidityd | |||
| Central nervous system disease | 7 (9) | 6 (8) | 0.772 |
| Cardiovascular disease | 16 (21) | 17 (23) | 0.844 |
| Respiratory disease | 4 (5) | 9 (12) | 0.147 |
| Gastrointestinal disease | 10 (13) | 11 (15) | 0.814 |
| Endocrine disease | 3 (4) | 3 (4) | 1.000 |
| Musculoskeletal disease | 11 (15) | 11 (15) | 1.000 |
Data are presented as number of women (percentage), mean (SD), or median (range)
P p value using chi-square test, Mann–Whitney, or t test as appropriate
aMedian (range)
bMean (SD)
cNote that data on one vaginal hysterectomy patient is missing
dNote that data on six cervical amputation patients are missing
Concomitant operations intra- and postoperative details
| Cervical amputation ( | Vaginal hysterectomy ( |
| |
|---|---|---|---|
| Concomitant operation | |||
| Anterior colporrhaphy | 63 (85) | 58 (92) | 0.161 |
| Posterior colporrhaphy | 54 (73) | 47 (75) | 0.493 |
| Perineoplasty | 18 (32) | 16 (26) | 0.308 |
| Intraoperativea | |||
| Operation time (min) | 78 (28) | 110 (35) | 0.000 |
| Intraoperative bloodloss (ml) | 191 (116) | 251 (149) | 0.006 |
| Postoperativea | |||
| Catheterization (days) | 3.7 (4) | 3.1 (2) | 0.198 |
| Length of hospitalisation (days) | 6.1 (3) | 5.2 (2) | 0.018 |
| Complications during hospital stay | |||
| Urinary retention | 9 (11) | 12 (16) | 0.277 |
| Bleeding | 0 | 1 (1) | 0.487 |
Data are presented as number of women (percentage) or mean (SD). Note: urinary retention was resolved with prolonged catheterisation or intermittent self-catheterisation, there were no long-term consequences; the patient with the bleeding received two packed cells and left the hospital in good condition
P p value using chi-square test or t test as appropriate
aMean (SD)
The nine points and distances from the pre- and postoperative pelvic organ prolapse quantification scores
| Preoperative values |
| Postoperative values (1 year) |
| |||
|---|---|---|---|---|---|---|
| Cervical amputation ( | Vaginal hysterectomy ( | Cervical amputation ( | Vaginal hysterectomy ( | |||
| Aa | 0.4 (1.6) | 0.8 (1.7) | 0.160 | −1.7 (1.2) | −1.7 (1.2) | 0.935 |
| Ba | 1.7 (2.1) | 2.0 (1.9) | 0.299 | −1.4 (1.2) | −1.6 (1.3) | 0.525 |
| C | −1.8 (2.6) | 0.4 (3.4) | 0.000 | −7.0 (1.1) | −6.8 (2.2) | 0.546 |
| GH | 4.5 (1.1) | 5.0 (1.1) | 0.006 | 4.0 (0.9) | 3.6 (0.9) | 0.027 |
| PB | 3.3 (1.0) | 3.7 (0.9) | 0.006 | 3.9 (0.9) | 3.6 (0.8) | 0.034 |
| TVL | 9.4 (0.9) | 9.7 (1.2) | 0.030 | 8.7 (0.9) | 8.9 (1.2) | 0.319 |
| Ap | −1.2 (1.3) | −0.9 (1.2) | 0.145 | −2.4 (0.9) | −2.5 (0.9) | 0.427 |
| Bp | −1.1 (1.3) | −0.7 (1.5) | 0.053 | −2.4 (1.2) | −2.4 (1.0) | 0.770 |
| D | −5.1 (2.0) | −3.8 (3.1) | 0.002 | −7.5 (1.2) | – | – |
Data are presented as mean (SD)
P p value using an independent samples Student’s t test
The overall and compartmental stages of the pre- and postoperative pelvic organ prolapse quantification examinations
| Preoperative | Postoperative 1 year | |||
|---|---|---|---|---|
| Cervical amputation ( | Vaginal hysterectomy ( | Cervical amputation ( | Vaginal hysterectomy ( | |
| Overall POP-Q stage | ||||
| Stage 0 | 0 (0) | 0 (0) | 6 (12.0) | 6 (18.8) |
| Stage 1 | 0 (0) | 1 (1.4) | 14 (28.0) | 13 (27.1) |
| Stage 2 | 24 (32.9) | 19 (26.4) | 29 (58.0) | 25 (52.1) |
| Stage 3 | 48 (65.8) | 51 (70.8) | 1 (2.0) | 1 (2.1) |
| Stage 4 | 1 (1.4) | 1 (1.4) | 0 (0) | 0 (0) |
| Anterior POP-Q stage (Ba) | ||||
| Stage 0 | 2 (2.7) | 0 (0) | 10 (20.0) | 17 (35.4) |
| Stage 1 | 2 (2.7) | 5 (6.9) | 17 (34.0) | 8 (16.7) |
| Stage 2 | 27 (37.0) | 22 (30.6) | 22 (44.0) | 23 (47.9) |
| Stage 3 | 41 (56.2) | 44 (61.1) | 1 (2.0) | 0 (0) |
| Stage 4 | 1 (1.4) | 1 (1.4) | 0 (0) | 0 (0) |
| Posterior POP-Q stage (Bp) | ||||
| Stage 0 | 8 (11.0) | 5 (6.9) | 30 (60.0) | 33 (68.8) |
| Stage 1 | 27 (37.0) | 14 (19.4) | 7 (14.0) | 8 (16.7) |
| Stage 2 | 33 (45.2) | 48 (66.7) | 13 (26.0) | 7 (14.6) |
| Stage 3 | 4 (5.5) | 4 (5.6) | 0 (0) | 0 (0) |
| Stage 4 | 1 (1.4) | 1 (1.4) | 0 (0) | 0 (0) |
| Vault/cervix POP-Q stage (C) | ||||
| Stage 0 | 0 (0) | 0 (0) | 23 (46.0) | 18 (37.5) |
| Stage 1 | 43 (58.9) | 24 (33.3) | 27 (54.0) | 28 (58.3) |
| Stage 2 | 20 (27.4) | 15 (20.8) | 0 (0) | 1 (2.1) |
| Stage 3 | 9 (12.3) | 32 (44.4) | 0 (0) | 1 (2.1) |
| Stage 4 | 1 (1.4) | 1 (1.4) | 0 (0) | 0 (0) |
Data are presented as n (%)
Preoperative scores and change in scores (preoperative minus postoperative scores) on the incontinence impact questionnaire, urogenital distress inventory, and defaecatory distress inventory
| Preoperative | Postoperative | Change between pre- and postoperative | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cervical amputation | Vaginal hysterectomy | Cervical amputation | Vaginal hysterectomy | Cervical amputation | Vaginal hysterectomy |
| ||||||||
| IIQ | ||||||||||||||
| Mobility | 28.7 (24.5) | 26.6 (22.0) | 23.7 (27.4) | 21.6 (25.8) | 8.3 (24.2) | 7.6 (19.3) | 0.900 | |||||||
| Physical | 29.0 (29.3) | 27.3 (29.5) | 22.6 (28.9) | 15.3 (28.3) | 6.4 (33.3) | 13.8 (26.4) | 0.301 | |||||||
| Social | 17.2 (20.4) | 13.2 (14.1) | 14.1 (24.5) | 9.2 (16.0) | 7.7 (16.3) | 6.0 (12.4) | 0.630 | |||||||
| Embarrassment | 18.4 (21.3) | 14.6 (16.9) | 14.4 (22.4) | 11.7 (22.4) | 6.2 (20.2) | 6.8 (19.8) | 0.890 | |||||||
| Emotion | 32.6 (28.1) | 25.9 (22.8) | 19.8 (23.4) | 16.2 (26.0) | 13.7 (23.4) | 12.8 (22.9) | 0.868 | |||||||
| UDI | ||||||||||||||
| Overactive bladder | 21.5 (20.5) | 28.5 (23.9) | 19.4 (19.7) | 18.1 (22.6) | 5.8 (19.8) | 6.5 (15.7) | 0.903 | |||||||
| Incontinence | 25.5 (25.5) | 24.0 (25.2) | 18.7 (20.1) | 17.2 (19.6) | 12.6 (25.6) | 6.4 (20.5) | 0.249 | |||||||
| Obstructive micturition | 26.0 (25.5) | 24.0 (25.2) | 13.4 (20.0) | 12.9 (22.1) | −7.8 (17.1) | −10.6 (19.9) | 0.523 | |||||||
| Discomfort/pain | 30.9 (24.3) | 30.6 (30.3) | 17.3 (20.3) | 9.4 (13.5) | 15.2 (22.6) | 18.8 (28.3) | 0.548 | |||||||
| Genital prolapse | 51.7 (33.4) | 54.0 (32.7) | 7.8 (14.7) | 10.5 (19.1) | 43.1 (35.0) | 41.9 (32.5) | 0.879 | |||||||
| DDI | ||||||||||||||
| Obstipation | 14.2 (18.7) | 11.9 (17.3) | 12.1 (18.6) | 7.8 (14.2) | 2.9 (14.8) | 5.0 (15.1) | 0.555 | |||||||
| Obstructive defaecation | 15.4 (19.4) | 14.2 (16.8) | 9.4 (13.7) | 5.3 (10.3) | 5.7 (14.6) | 9.5 (15.5) | 0.307 | |||||||
| Discomfort/pain | 14.2 (23.0) | 12.2 (23.5) | 9.0 (17.2) | 3.1 (9.9) | 4.4 (25.1) | 7.0 (18.4) | 0.621 | |||||||
| Incontinence | 2.4 (7.7) | 6.0 (13.7) | 5.2 (16.8) | 5.6 (15.5) | −1.0 (12.7) | 0.9 (22.6) | 0.669 | |||||||
| Flatus | 21.2 (27.4) | 22.5 (25.4) | 20.1 (26.4) | 24.4 (26.7) | −4.0 (24.2) | −3.7 (19.2) | 0.959 | |||||||
Data are presented as mean (SD). Note: the change is presented as the mean of the individual score per patient (preoperative score minus postoperative score), consequently, positive values indicate an improvement; whereas, negative values indicate a deterioration in outcome
P p value using an independent t test on the difference between the groups in change of preoperative minus postoperative scores, IIQ incontinence impact questionnaire, UDI urogenital distress inventory, DDI defaecatory distress inventory